This Company Just Withdrew Two of Its Drug Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma
According to a story from BioPharma Dive, the drug company AbbVie has recently announced its decision to withdraw two different approvals for its cancer therapy Imbruvica. The approvals were withdrawn…